Related references
Note: Only part of the references are listed.Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update
Arrigo F. G. Cicero et al.
MEDICINA-LITHUANIA (2021)
Effects of Probenecid on Hepatic and Renal Disposition of Hexadecanedioate, an Endogenous Substrate of Organic Anion Transporting Polypeptide 1B in Rats
Azusa Futatsugi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
G-Protein-Coupled Receptor and Ion Channel Genes Used by Influenza Virus for Replication
Nichole Orr-Burks et al.
JOURNAL OF VIROLOGY (2021)
Immunopathology of RSV: An Updated Review
Harrison C. Bergeron et al.
VIRUSES-BASEL (2021)
Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro
Jackelyn Murray et al.
SCIENTIFIC REPORTS (2021)
Emerging small and large molecule therapeutics for respiratory syncytial virus
Harrison C. Bergeron et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Up-to-date role of biologics in the management of respiratory syncytial virus
Seyhan Boyoglu-Barnum et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Priorities for developing respiratory syncytial virus vaccines in different target populations
Simon B. Drysdale et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Current Insights in the Development of Efficacious Vaccines Against RSV
Jorge A. Soto et al.
FRONTIERS IN IMMUNOLOGY (2020)
Organic Cation Transporters in the Lung-Current and Emerging (Patho)Physiological and Pharmacological Concepts
Mohammed Ali Selo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
Farnaz Foolad et al.
CLINICAL INFECTIOUS DISEASES (2019)
Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
Maria Jose Altamirano-Lagos et al.
FRONTIERS IN MICROBIOLOGY (2019)
Effectiveness of Palivizumab against Respiratory Syncytial Virus: Cohort and Case Series Analysis
Hannah C. Moore et al.
JOURNAL OF PEDIATRICS (2019)
Antibiotic Minocycline Prevents Respiratory Syncytial Virus Infection
Swapnil S. Bawage et al.
VIRUSES-BASEL (2019)
Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model
Hayat Caidi et al.
ANTIVIRAL RESEARCH (2018)
Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value
Natalia Olchanski et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes
Wei Wu et al.
SCIENTIFIC REPORTS (2017)
Repositioning of drugs using open-access data portal DTome: A test case with probenecid (Review)
Mohammad U. Ahmed et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication
Olivia Perwitasari et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2015)
THE ORGANIC ANION TRANSPORTER (OAT) FAMILY: A SYSTEMS BIOLOGY PERSPECTIVE
Sanjay K. Nigam et al.
PHYSIOLOGICAL REVIEWS (2015)
Respiratory Syncytial Virus Human Experimental Infection Model: Provenance, Production, and Sequence of Low-Passaged Memphis-37 Challenge Virus
Young-In Kim et al.
PLOS ONE (2014)
Respiratory syncytial virus: current and emerging treatment options
Tiffany L. Turner et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2014)
Targeting Organic Anion Transporter 3 with Probenecid as a Novel Anti-Influenza A Virus Strategy
Olivia Perwitasari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
siRNA Genome Screening Approaches to Therapeutic Drug Repositioning
Olivia Perwitasari et al.
PHARMACEUTICALS (2013)
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens
Victoria A. Meliopoulos et al.
FASEB JOURNAL (2012)
The dependence of viral RNA replication on co-opted host factors
Peter D. Nagy et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Genomic Screening with RNAi: Results and Challenges
Stephanie Mohr et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children
Robert C. Welliver et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Inhibition of Na+ Transport in Lung Epithelial Cells by Respiratory Syncytial Virus Infection
Lan Chen et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Respiratory Syncytial Virus Grown in Vero Cells Contains a Truncated Attachment Protein That Alters Its Infectivity and Dependence on Glycosaminoglycans
Steven Kwilas et al.
JOURNAL OF VIROLOGY (2009)
Probenecid, a gout remedy, inhibits pannexin 1 channels
William Silverman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
New low-viscosity overlay medium for viral plaque assays
Mikhail Matrosovich et al.
VIROLOGY JOURNAL (2006)
The human organic anion transporter 3 (OAT3; SLC22A8):: genetic variation and functional genomics
AR Erdman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P
LM Haynes et al.
JOURNAL OF VIROLOGY (2003)
Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection
LM Haynes et al.
JOURNAL OF VIROLOGY (2002)
Share Paper
